Drug-drug Interaction (DDI) Study of GSK3640254 With Darunavir/Ritonavir (DRV/RTV) and Etravirine (ETR)
Status:
Completed
Trial end date:
2021-10-02
Target enrollment:
Participant gender:
Summary
This is an open-label, single-sequence, multiple-dose, 3 cohort study to investigate the
effects of DRV/RTV and/or ETR on the pharmacokinetics (PK) of GSK3640254 and the effects of
GSK3640254 on the PK of DRV/RTV and/or ETR. This study will aid in understanding these
interactions and resulting changes in exposure (if any) when given in combination with
GSK3640254.